| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/12/2013 | WO2012071453A8 Modulating oncolytic vsv and upregulating rae1 and nup98 with statins |
| 09/12/2013 | US20130239239 Lmcd1 cancer markers and methods for their use |
| 09/12/2013 | US20130239234 Phosphodiesterase activity and regulation of phosphodiesterase 1b-mediated signaling in brain |
| 09/12/2013 | US20130237691 Usp2a peptides and antibodies |
| 09/12/2013 | US20130237689 Soluble hla class ii complexes and methods of production and use thereof |
| 09/12/2013 | US20130237557 Treatment |
| 09/12/2013 | US20130237454 Diagnostic markers for neuropsychiatric disease |
| 09/12/2013 | US20130237453 Systems, methods and devices for measuring growth/oncogenic and migration/metastatic potential |
| 09/12/2013 | US20130237452 Screening method for selecting plants that show a reduced wound-induced surface discolouration |
| 09/12/2013 | US20130237445 Methods and kits for detecting melanoma |
| 09/12/2013 | US20130237442 Methods and Compositions for Diagnosis of Non-Viable Early Pregnancy |
| 09/12/2013 | US20130237439 Systems and methods using biomarker panel data |
| 09/12/2013 | US20130237433 Detection of nucleic acids and proteins |
| 09/12/2013 | US20130237430 Protein or peptide printing method, protein array or peptide array and functional protein or functional peptide identification method |
| 09/12/2013 | US20130236986 Methods of separating nucleic acid polymer conjugates |
| 09/12/2013 | US20130236983 Oilfield Chemicals with Attached Spin Probes |
| 09/12/2013 | US20130236979 Methods for detecting vitamin d metabolites by mass spectrometry |
| 09/12/2013 | US20130236978 Methods and Compositions for Biomarkers of Fatigue, Fitness and Physical Performance Capacity |
| 09/12/2013 | US20130236977 Compositions and methods for plasma peptide analysis |
| 09/12/2013 | US20130236920 Post protein hydrolysis removal of a potent ribonuclease inhibitor and the enzymatic capture of dna |
| 09/12/2013 | US20130236919 Methods and compositions for diagnosing and treating mood disorders |
| 09/12/2013 | US20130236918 Sandwich assay for immunosuppressant drugs |
| 09/12/2013 | US20130236917 Albumin-bound protein/peptide complex as a biomarker for disease |
| 09/12/2013 | US20130236916 D-dimer, troponin, and nt-probnp for pulmonary embolism |
| 09/12/2013 | US20130236915 Method of inspecting periodontal disease causing bacteria using outer membrane vesicle and measuring appliance of the same |
| 09/12/2013 | US20130236914 Devices and methods for analysis of samples with depletion of analyte content |
| 09/12/2013 | US20130236913 Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells |
| 09/12/2013 | US20130236912 Use Of Quinolinone Derivatives As A Research Tool |
| 09/12/2013 | US20130236910 Test method and apparatus |
| 09/12/2013 | US20130236908 Method for predicting a need for renal replacement therapy (rrt) |
| 09/12/2013 | US20130236906 Diagnostic method for the detection of cells ex vivo |
| 09/12/2013 | US20130236905 Assay for identifying antigens that activate b cell receptors comprising neutralizing antibodies |
| 09/12/2013 | US20130236902 Collection and Methods For Its Use |
| 09/12/2013 | US20130236899 Methods And Compositions For Detecting Multiple Analytes With A Single Signal |
| 09/12/2013 | US20130236890 Novel method for analyzing circulating tumor cells of a patient for the presence of metastasis-initiating cells |
| 09/12/2013 | US20130236889 Vascularization Inhibitors |
| 09/12/2013 | US20130236887 Method and Apparatus for Measuring Analyte Transport Across Barriers |
| 09/12/2013 | US20130236883 Process of directly detecting and identifying a microorganism in a biological sample diluted in an enrichment broth |
| 09/12/2013 | US20130236882 Micro-Devices for Improved Disease Detection |
| 09/12/2013 | US20130236881 Three-dimensional metal-coated nanostructures on substrate surfaces, method for producing same and use thereof |
| 09/12/2013 | US20130236879 Three-dimensional, prevascularized, engineered tissue constructs, methods of making and methods of using the tissue constructs |
| 09/12/2013 | US20130236487 Designer peptide-based pcv2 vaccine |
| 09/12/2013 | US20130236484 Leishmaniasis antigen detection assays and vaccines |
| 09/12/2013 | US20130236458 Dual specific binding proteins directed against il-13 and/or il-17 |
| 09/12/2013 | US20130236440 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
| 09/12/2013 | US20130236404 Substances and compositions for enhancing dna repair and methods of use |
| 09/12/2013 | US20130236398 Antibodies that bind to nanoparticles |
| 09/12/2013 | US20130236394 Thioflavin derivatives for use in antemortem diagnosis of alzheimer`s disease and in vivo imaging and prevention of amyloid deposition |
| 09/12/2013 | US20130235185 Building inspection device |
| 09/12/2013 | US20130234071 Composition of human synthetic urine |
| 09/12/2013 | US20130233063 Sensor for Determining Contact |
| 09/12/2013 | US20130233057 Device For Analyzing At Least One Hydrocarbon Contained In A Drilling Fluid And Associated Method |
| 09/12/2013 | DE112011103687T5 Zentromerdetektor und Methode zur Bestimmung der Strahlenbelastung durch Chromosomabnormalitäten Centromere detector and method for the determination of exposures from chromosome abnormalities |
| 09/12/2013 | DE102012004794A1 Method for monitoring condition of engine oil of internal combustion engine, involves comparing detected operating time and oil temperature with predetermined threshold values and reviewing actual operation as cold start |
| 09/12/2013 | DE102012002027B4 Messeinrichtung zur Bestimmung der Sauerstoffaktivität in Metall- oder Schlackeschmelzen Measuring device for determining the oxygen activity in metal or slag melts |
| 09/11/2013 | EP2637026A1 Non-proteolytic method for the determination of analytes in keratinized structures |
| 09/11/2013 | EP2637025A2 Screening method for detecting samples with impaired GPIb-Von Willebrand factor interaction functionality |
| 09/11/2013 | EP2637024A1 Screening method for detecting samples with impaired GPIb-Von Willebrand factor interaction functionality |
| 09/11/2013 | EP2637023A1 Prediction of outcome in patients with chronic obstructive pulmonary disease |
| 09/11/2013 | EP2637022A1 Method of inspecting periodontal disease causing bacteria using outer membrane vesicle and measuring appliance of the same |
| 09/11/2013 | EP2637021A1 Method and device for detecting analytes |
| 09/11/2013 | EP2637020A2 Predictive markers for ovarian cancer |
| 09/11/2013 | EP2637019A1 Method for determining the production of reactive oxygen species in a cellular population |
| 09/11/2013 | EP2637016A1 Imaging device, method for processing images captured by said imaging device, and image capture system |
| 09/11/2013 | EP2637015A1 Cell analyzer |
| 09/11/2013 | EP2636752A1 In vitro method for determining disease outcome in pulmonary carcinoids. |
| 09/11/2013 | EP2636751A2 Method for determining a body fluid |
| 09/11/2013 | EP2636732A1 Sub-totipotent stem cell product and apparent hereditary modifying label thereof |
| 09/11/2013 | EP2636731A1 Method of producing intestinal cells |
| 09/11/2013 | EP2636469A1 Blue-colored gold nanoparticles for immunological measurement, process for production of same, and measurement method using same |
| 09/11/2013 | EP2636413A1 Chimeric virus-like particles (VLP) containing functional hMPV proteins |
| 09/11/2013 | EP2635966A1 Biomarkers for predicting progressive joint damage |
| 09/11/2013 | EP2635909A2 Factors |
| 09/11/2013 | EP2635908A1 Serum mg53 as a diagnostic marker for tissue injury |
| 09/11/2013 | EP2635907A1 Ice cleaved alpha-synuclein a biomarker |
| 09/11/2013 | EP2635906A2 Ice inhibiting compounds and uses thereof |
| 09/11/2013 | EP2635905A2 Efficient and effective supplement screening for the development of chemically defined media in cell culture |
| 09/11/2013 | EP2635904A1 Prognosis and risk assessment of patients with non-specific complaints |
| 09/11/2013 | EP2635903A1 Method and apparatus for examining eggs |
| 09/11/2013 | EP2635902A1 A method of calibrating an air sensor |
| 09/11/2013 | EP2635893A2 Temperature calibration methods and apparatus for optical absorption gas sensors, and optical absorption gas sensors thereby calibrated |
| 09/11/2013 | EP2635891A1 Method and devices for analyzing components contained in the air |
| 09/11/2013 | EP2635871A2 On-chip 4d lightfield microscope |
| 09/11/2013 | EP2635710A2 Optical analyte detection systems and methods of use |
| 09/11/2013 | EP2635707A1 Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease |
| 09/11/2013 | EP2635695A1 Method for detecting a plasmodium infection |
| 09/11/2013 | EP2635680A2 Differential detection and quantification of oxalobacter |
| 09/11/2013 | EP2635674A1 Markers of endothelial progenitor cells and uses thereof |
| 09/11/2013 | EP2635611A1 Release reagent for vitamin d |
| 09/11/2013 | EP2635597A1 Information acquisition method |
| 09/11/2013 | EP2635494A1 A method of production, apparatus and system |
| 09/11/2013 | EP2635346A1 Optogenetic control of reward-related behaviors |
| 09/11/2013 | EP2635304A2 Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers |
| 09/11/2013 | EP2635111A2 Stabilized step function opsin proteins and methods of using the same |
| 09/11/2013 | EP2635110A2 Control and characterization of psychotic states |
| 09/11/2013 | CN203191384U Furazolidone metabolite fluorescent quantitative detection system |
| 09/11/2013 | CN203191383U Yellow fever magnetic test paper |
| 09/11/2013 | CN203191382U Immunoblotting kit for detecting multiple antinuclear antibodies |
| 09/11/2013 | CN203191381U Test standard plate for raster type fluorescent Elisa analyzer |
| 09/11/2013 | CN203191380U Full-automatic chemiluminescence immunoassay analyzer |